(Q34539713)

2 August 2017

1 reference

title

The role of sex hormones in psychopathology: focus on schizophrenia (English)

1 reference

2 August 2017

0 references

Mary V Seeman

1

1 reference

2 August 2017

publication date

1 March 2002

1 reference

Primary Care: Clinics in Office Practice

2 August 2017

published in

1 reference

2 August 2017

volume

29

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

171-82, viii

1 reference

Role of estrogens in peripheral and cerebral glucose utilization

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Emerging diversities in the mechanism of action of steroid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Gender differences in patients with schizophrenia and substance abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Are adolescents the victims of raging hormones: evidence for activational effects of hormones on moods and behavior at adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

The incidence of operationally defined schizophrenia in Camberwell, 1965-84.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Perspectives of women living with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Duration of pretreatment phases in schizophrenia: women and men

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Sex differences in neuroanatomical and clinical correlations in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Gender, premorbid characteristics and negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Influence of the menstrual cycle phase on the therapeutic response in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Psychotropic drugs in pregnancy and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Gender and the expression of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Gender and mortality in schizophrenia: do women act like men?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Gender and schizophrenia outcome: a clinical trial of an inpatient family intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Epidemiology of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Causes and consequences of the gender difference in age at onset of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Variation in symptom severity over the menstrual cycle of schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Neuroleptic intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Predicting the long-term outcome of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Gender as a Risk Factor for Adverse Events to Medications

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Differential olanzapine plasma concentrations by sex in a fixed-dose study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Sex differences in olfactory function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

A clinical trial of the effects of estrogen in acutely psychotic women

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Testosterone and dominance in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Steroid hormones: effect on brain development and function

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Estrogen actions in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Sexuality, reproduction, and family planning in women with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Chapter 2. Gonadal Steroid Receptors: Possible Roles in the Etiology and Therapy of Cognitive and Neurological Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

In search of optimal long-term female hormone replacement: the potential of selective estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Mortality and causes of death in first admitted schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Brain-derived neurotrophic factor mediates estradiol-induced dendritic spine formation in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Long-term clinical outcome of schizophrenia with special reference to gender differences

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Differences between male and female brains--developmental mechanisms and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Lack of gender differences in neuroleptic response in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Current outcome in schizophrenia: women vs men

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Psychopathology in women and men: focus on female hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Narratives of twenty to thirty year outcomes in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

A service for women with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Estrogen protects primary cortical neurons from glutamate toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Female sex steroid hormones: from receptors to networks to performance--actions on the sensorimotor system

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Molecular mechanisms of action of steroid/thyroid receptor superfamily members

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900080-0

7 January 2021

10.1016/S0095-4543(03)00080-0

Identifiers

DOI

1 reference

2 August 2017

1 reference